Frontier Wealth Management LLC Alkermes Plc. Transaction History

Frontier Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$21.47 - $37.33 $345,667 - $601,013	-16,100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $735,247 - $944,689	-25,889 Reduced 61.66%	16,100 $587,000
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $292,280 - $466,665	-10,461 Reduced 19.94%	41,989 $1.24 Million
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $355,120 - $424,304	-9,200 Reduced 14.92%	52,450 $2.23 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $186,576 - $236,256	-4,600 Reduced 6.94%	61,650 $2.54 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $67,012 - $84,075	-1,250 Reduced 1.85%	66,250 $3.84 Million
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $214,605 - $249,255	-4,500 Reduced 6.25%	67,500 $3.69 Million
Q3 2017 Nov 13, 2017	SELL	$49.16 - $54.45 $54,075 - $59,895	-1,100 Reduced 1.5%	72,000 $3.66 Million
Q2 2017 Aug 14, 2017	BUY	N/A	73,100	73,100 $4.24 Million

358

180M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.22B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.